Knight Therapeutics and Sumitomo Pharma enter into Exclusive Licensing Agreements to commercialize Sumitomo's Canadian Portfolio

Jun 5, 2025 - 12:00

0

Knight Therapeutics and Sumitomo Pharma enter into Exclusive Licensing Agreements to commercialize Sumitomo's Canadian Portfolio

Related Posts

Elon Musk says DOGE cuts necessary, but face headwinds according to Fox poll

Elon Musk says DOGE cuts necessary, but face headwinds ...

Mar 21, 2025 0

Airlines issue travel waivers due to London's Heathrow Airport shutdown

Airlines issue travel waivers due to London's Heathrow ...

Mar 21, 2025 0

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025 0

Disney investor pledges to continue fight as shareholders reject proposal to distance company from LGBT group

Disney investor pledges to continue fight as shareholde...

Mar 21, 2025 0

Elon Musk reassures Tesla workers with all-hands meeting, admits it 'feels like Armageddon'

Elon Musk reassures Tesla workers with all-hands meetin...

Mar 21, 2025 3

Businesses may have to pass high beef prices on to consumers

Businesses may have to pass high beef prices on to cons...

Mar 21, 2025 0